Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
September 07, 2022 16:15 ET
|
Silk Road Medical
SUNNYVALE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced enrollment...
Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
August 30, 2022 16:15 ET
|
Silk Road Medical
SUNNYVALE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company...
Silk Road Medical Reports Second Quarter 2022 Financial Results
July 26, 2022 16:05 ET
|
Silk Road Medical
SUNNYVALE, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial...
Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022
July 12, 2022 16:15 ET
|
Silk Road Medical
SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will...
Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR
June 15, 2022 09:00 ET
|
Silk Road Medical
SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced a...
Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients
June 02, 2022 07:00 ET
|
Silk Road Medical
SUNNYVALE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the...
Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing
May 31, 2022 09:00 ET
|
Silk Road Medical
SUNNYVALE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Company) (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced...
Silk Road Medical Reports First Quarter 2022 Financial Results
May 04, 2022 16:05 ET
|
Silk Road Medical
SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial...
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
May 02, 2022 08:30 ET
|
Silk Road Medical
SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the...
Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference
April 26, 2022 16:10 ET
|
Silk Road Medical
SUNNYVALE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company...